2023 Q4 Form 10-Q Financial Statement

#000160706223000499 Filed on November 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q4
Revenue $640.00 $10.58K $0.00
YoY Change
Cost Of Revenue $9.720K $20.82K $29.71K
YoY Change -67.28%
Gross Profit -$9.080K -$10.24K -$29.71K
YoY Change -69.44%
Gross Profit Margin -1418.75% -96.82%
Selling, General & Admin $140.2K $106.9K $64.53K
YoY Change 117.28% 126.61% 140.34%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $6.420K $5.851K
YoY Change
% of Gross Profit
Operating Expenses $140.2K $127.7K $64.53K
YoY Change 117.28% 170.75% 140.34%
Operating Profit -$149.3K -$117.1K -$94.24K
YoY Change 58.41% 148.32%
Interest Expense -$15.89K $15.59K $20.00
YoY Change -79550.0% -122.22%
% of Operating Profit
Other Income/Expense, Net $12.00K -$3.594K
YoY Change
Pretax Income -$153.2K -$120.7K -$94.22K
YoY Change 62.58% 155.94% 249.87%
Income Tax
% Of Pretax Income
Net Earnings -$153.2K -$120.7K -$94.22K
YoY Change 62.58% 155.93% 249.87%
Net Earnings / Revenue -23934.38% -1141.09%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 107.8M shares 107.8M shares 35.95M shares
Diluted Shares Outstanding 107.8M shares

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $22.07K $3.290K $142.4K
YoY Change -84.5% -98.46% 4162.57%
Cash & Equivalents $22.07K $3.286K $142.4K
Short-Term Investments
Other Short-Term Assets $5.100K $5.100K $0.00
YoY Change
Inventory
Prepaid Expenses
Receivables $8.000K
Other Receivables $0.00
Total Short-Term Assets $27.17K $16.39K $142.4K
YoY Change -80.92% -92.34% 4162.43%
LONG-TERM ASSETS
Property, Plant & Equipment $163.4K $166.9K $0.00
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $189.4K $192.9K $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $27.17K $16.39K $142.4K
Total Long-Term Assets $189.4K $192.9K $0.00
Total Assets $216.6K $209.3K $142.4K
YoY Change 52.11% -2.21% 4162.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $147.1K $90.02K $37.87K
YoY Change 288.3% 197.64% -31.06%
Accrued Expenses $100.8K $79.22K $29.77K
YoY Change 238.76% 684.07%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $191.4K $46.11K $0.00
YoY Change
Total Short-Term Liabilities $338.5K $201.1K $37.87K
YoY Change 793.82% 349.22% -63.91%
LONG-TERM LIABILITIES
Long-Term Debt $840.2K $879.6K $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $840.2K $879.6K $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $338.5K $201.1K $37.87K
Total Long-Term Liabilities $840.2K $879.6K $0.00
Total Liabilities $1.179M $1.081M $37.87K
YoY Change 3012.44% 2313.72% -63.91%
SHAREHOLDERS EQUITY
Retained Earnings -$37.56M -$37.40M -$36.24M
YoY Change 3.63% 3.48% 0.42%
Common Stock $36.60M $36.54M $36.35M
YoY Change 0.69% 0.6% 0.99%
Preferred Stock
YoY Change
Treasury Stock (at cost) $3.336K $3.336K $3.336K
YoY Change 0.0% 0.0% 0.0%
Treasury Stock Shares
Shareholders Equity -$962.1K -$871.4K $104.5K
YoY Change
Total Liabilities & Shareholders Equity $216.6K $209.3K $142.4K
YoY Change 52.11% -2.21% 4162.43%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q4
OPERATING ACTIVITIES
Net Income -$153.2K -$120.7K -$94.22K
YoY Change 62.58% 155.93% 249.87%
Depreciation, Depletion And Amortization $6.420K $5.851K
YoY Change
Cash From Operating Activities -$57.35K -$49.48K -$70.82K
YoY Change -19.02% -2.54% 476.71%
INVESTING ACTIVITIES
Capital Expenditures $2.900K $5.740K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities -$2.900K -$5.740K $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 79.03K 39.86K -820.0
YoY Change -9737.8% -84.16% -105.26%
NET CHANGE
Cash From Operating Activities -57.35K -49.48K -70.82K
Cash From Investing Activities -2.900K -5.740K 0.000
Cash From Financing Activities 79.03K 39.86K -820.0
Net Change In Cash 18.78K -15.36K -71.64K
YoY Change -126.21% -107.65% -2257.83%
FREE CASH FLOW
Cash From Operating Activities -$57.35K -$49.48K -$70.82K
Capital Expenditures $2.900K $5.740K
Free Cash Flow -$60.25K -$55.22K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Payments For Purchase Of Other Assets1
PaymentsForPurchaseOfOtherAssets1
usd
dei Entity Central Index Key
EntityCentralIndexKey
0001113313
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2022Q4 AVNI Notes Payable Related Party Classified Current
NotesPayableRelatedPartyClassifiedCurrent
usd
CY2022Q4 AVNI Notes Payable Related Party Noncurrent
NotesPayableRelatedPartyNoncurrent
usd
CY2022Q3 AVNI Revenues Charter Income
RevenuesCharterIncome
usd
AVNI Revenues Charter Income
RevenuesCharterIncome
usd
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
usd
us-gaap Costs And Expenses
CostsAndExpenses
usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
usd
us-gaap Gross Profit
GrossProfit
usd
CY2022Q3 us-gaap Lease Income
LeaseIncome
usd
us-gaap Lease Income
LeaseIncome
usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
usd
CY2023Q3 us-gaap Other Income
OtherIncome
usd
CY2022Q3 us-gaap Other Income
OtherIncome
usd
us-gaap Other Income
OtherIncome
usd
CY2023Q3 us-gaap Payments For Purchase Of Other Assets1
PaymentsForPurchaseOfOtherAssets1
usd
CY2022Q3 us-gaap Payments For Purchase Of Other Assets1
PaymentsForPurchaseOfOtherAssets1
usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
us-gaap Depreciation
Depreciation
usd
us-gaap Payments For Purchase Of Other Assets1
PaymentsForPurchaseOfOtherAssets1
usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
AVNI Incurred Share Issuance Costs
IncurredShareIssuanceCosts
usd
us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
usd
CY2022Q4 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-30695
dei Entity Registrant Name
EntityRegistrantName
ARVANA INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0618509
dei Entity Address Address Line1
EntityAddressAddressLine1
299 Main Street
dei Entity Address Address Line2
EntityAddressAddressLine2
13th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
Salt Lake City
dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84111
dei City Area Code
CityAreaCode
(801)
dei Local Phone Number
LocalPhoneNumber
232-7395
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
107839299 shares
CY2023Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
3286 usd
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
142365 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8000 usd
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
5100 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
0 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
16386 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
142365 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
166897 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
0 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
26000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
0 usd
CY2023Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
192897 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
0 usd
CY2023Q3 us-gaap Assets
Assets
209283 usd
CY2022Q4 us-gaap Assets
Assets
142365 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
79222 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
29770 usd
CY2023Q3 AVNI Due To Related Party Current
DueToRelatedPartyCurrent
10800 usd
CY2022Q4 AVNI Due To Related Party Current
DueToRelatedPartyCurrent
8100 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
127713 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
47171 usd
us-gaap Operating Expenses
OperatingExpenses
405267 usd
us-gaap Operating Expenses
OperatingExpenses
71588 usd
CY2023Q3 AVNI Notes Payable Related Party Classified Current
NotesPayableRelatedPartyClassifiedCurrent
65000 usd
CY2023Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
46114 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
201136 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
37870 usd
CY2023Q3 AVNI Notes Payable Related Party Noncurrent
NotesPayableRelatedPartyNoncurrent
27644 usd
CY2023Q3 AVNI Notes Payable Noncurrent
NotesPayableNoncurrent
851940 usd
CY2022Q4 AVNI Notes Payable Noncurrent
NotesPayableNoncurrent
0 usd
CY2023Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
879584 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
0 usd
CY2023Q3 us-gaap Liabilities
Liabilities
1080720 usd
CY2022Q4 us-gaap Liabilities
Liabilities
37870 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
107845554 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
107839299 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
107847 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
107847 usd
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
36427816 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
36240352 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-37403764 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-36240368 usd
CY2023Q3 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
-868101 usd
CY2022Q4 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
107831 usd
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
6255 shares
CY2023Q3 us-gaap Treasury Stock Value
TreasuryStockValue
3336 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
3336 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-871437 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
104496 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
209283 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
142365 usd
CY2023Q3 AVNI Revenues Charter Income
RevenuesCharterIncome
10580 usd
AVNI Revenues Charter Income
RevenuesCharterIncome
23634 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
20824 usd
us-gaap Costs And Expenses
CostsAndExpenses
40936 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
-10244 usd
us-gaap Gross Profit
GrossProfit
-17302 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
93061 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
41989 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
307459 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
58845 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
13828 usd
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
5182 usd
us-gaap Professional Fees
ProfessionalFees
56872 usd
us-gaap Professional Fees
ProfessionalFees
12743 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-117133 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-47171 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-381633 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-71588 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
104496 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
187464 usd
us-gaap Net Income Loss
NetIncomeLoss
-1163396 usd
CY2023Q3 us-gaap Lease Income
LeaseIncome
12000 usd
us-gaap Lease Income
LeaseIncome
32000 usd
CY2023Q3 us-gaap Interest Income Operating
InterestIncomeOperating
0 usd
CY2022Q3 us-gaap Interest Income Operating
InterestIncomeOperating
0 usd
us-gaap Interest Income Operating
InterestIncomeOperating
5 usd
us-gaap Interest Income Operating
InterestIncomeOperating
0 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
15594 usd
us-gaap Interest Expense
InterestExpense
42759 usd
us-gaap Interest Expense
InterestExpense
587 usd
us-gaap Other Income
OtherIncome
15000 usd
us-gaap Payments For Purchase Of Other Assets1
PaymentsForPurchaseOfOtherAssets1
771009 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3594 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-781763 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
14413 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-120727 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-47171 usd
us-gaap Net Income Loss
NetIncomeLoss
-1163396 usd
us-gaap Net Income Loss
NetIncomeLoss
-57175 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107839299 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107839299 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107839299 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107839299 shares
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-111589 usd
CY2022Q3 AVNI Issuance Of Common Stock
IssuanceOfCommonStock
4800000 shares
CY2022Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
320000 usd
CY2022Q3 AVNI Incurred Share Issuance Costs
IncurredShareIssuanceCosts
-32000 usd
CY2022Q3 AVNI Conversion Of Related Party Debt To Equity Shares
ConversionOfRelatedPartyDebtToEquityShares
600000 shares
CY2022Q3 AVNI Conversion Of Related Party Debt To Equity
ConversionOfRelatedPartyDebtToEquity
40000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-47171 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-169240 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-801252 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
50542 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-120727 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-871437 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-101585 usd
AVNI Issuance Of Common Stock
IssuanceOfCommonStock
4800000 shares
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
320000 usd
AVNI Incurred Share Issuance Costs
IncurredShareIssuanceCosts
-32000 usd
AVNI Conversion Of Related Party Debt To Equity Shares
ConversionOfRelatedPartyDebtToEquityShares
600000 shares
AVNI Conversion Of Related Party Debt To Equity
ConversionOfRelatedPartyDebtToEquity
40000 usd
us-gaap Net Income Loss
NetIncomeLoss
-57175 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-169240 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-871437 usd
us-gaap Net Income Loss
NetIncomeLoss
-1163396 usd
us-gaap Net Income Loss
NetIncomeLoss
-57175 usd
us-gaap Depreciation
Depreciation
17552 usd
us-gaap Share Based Compensation
ShareBasedCompensation
187464 usd
us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
us-gaap Payments For Purchase Of Other Assets1
PaymentsForPurchaseOfOtherAssets1
771009 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-8000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
44542 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-14582 usd
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
2056 usd
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
9931 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-148773 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-61826 usd
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
50000 usd
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
-0 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-4089 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-51654 usd
AVNI Proceeds From Loans Payable
ProceedsFromLoansPayable
70766 usd
AVNI Proceeds From Loans Payable
ProceedsFromLoansPayable
35224 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
320000 usd
AVNI Incurred Share Issuance Costs
IncurredShareIssuanceCosts
-32000 usd
us-gaap Payments For Loans
PaymentsForLoans
9418 usd
us-gaap Payments For Loans
PaymentsForLoans
50724 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
61348 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
272500 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-139079 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
210674 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
142365 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3340 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3286 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
214014 usd
us-gaap Interest Paid Net
InterestPaidNet
22318 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
AVNI Related Party Payable Reduced Through Issuance Of Shares
RelatedPartyPayableReducedThroughIssuanceOfShares
40000 usd
AVNI Acquisition
Acquisition
700000 usd
AVNI Acquisition
Acquisition
0 usd
us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
234904 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_840_eus-gaap--UseOfEstimates_z5in5zRgwa39" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_86A_zY3pwvJ7CmcF" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Use of Estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of unaudited consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. These estimates include the recognition of deferred tax assets based on the change in unrecognized deductible temporary tax differences.</span></p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_z1d1dkriDxX8" style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_86F_zWiwJqRtdM9s" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Concentration of Credit Risk</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash. The Company maintains cash in bank accounts that, at times, may exceed federally insured limits. At September 30, 2023 and December 31, 2022 respectively, the Company did not have any cash in excess of the insured FDIC limits. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant risks on its cash in bank account.</span></p>
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7950000 shares
us-gaap Net Income Loss
NetIncomeLoss
-1163396 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-120727 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-37403764 usd
CY2023Q3 AVNI Working Capital
WorkingCapital
184750 usd
us-gaap Payments For Purchase Of Other Assets1
PaymentsForPurchaseOfOtherAssets1
771009 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
4089 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
5100 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
178706 usd
CY2023Q1 AVNI Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Commercial Fishing License
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCommercialFishingLicense
26000 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
213895 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
4910 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
644 usd
CY2023Q1 AVNI Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Payable To Affiliates
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPayableToAffiliates
62634 usd
CY2023Q1 AVNI Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Notes Payable
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNotesPayable
166716 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
234904 usd
CY2023Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
750000 usd
CY2023Q1 AVNI Business Combination Loss On Asset Acquisition
BusinessCombinationLossOnAssetAcquisition
771009 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
184449 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
0 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
17552 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
-0 usd
CY2023Q3 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
166897 usd
CY2022Q4 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
0 usd
us-gaap Depreciation
Depreciation
17552 usd
CY2023Q3 us-gaap Depreciation
Depreciation
5851 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Sale Leaseback Transaction Monthly Rental Payments
SaleLeasebackTransactionMonthlyRentalPayments
4000 usd
us-gaap Lease Income
LeaseIncome
32000 usd
CY2023Q3 us-gaap Lease Income
LeaseIncome
12000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
44000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
48000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
48000 usd
CY2022 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
4800000 shares
CY2022Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.07
CY2022Q4 AVNI Restricted Common Stock Total Proceeds
RestrictedCommonStockTotalProceeds
320000 usd
CY2022 AVNI Incurred Share Issuance Costs
IncurredShareIssuanceCosts
32237 usd
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
898054 usd
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
107845554 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
107839299 shares
CY2022Q3 AVNI Issuance Of Common Stock
IssuanceOfCommonStock
4800000 shares
CY2022Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.07
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
320000 usd
CY2023Q3 AVNI Accrued Payroll Included In Amounts Due To Related Parties
AccruedPayrollIncludedInAmountsDueToRelatedParties
10000 usd
CY2022Q4 AVNI Accrued Payroll Included In Amounts Due To Related Parties
AccruedPayrollIncludedInAmountsDueToRelatedParties
7500 usd
CY2023Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
800 usd
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
600 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7950000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.09
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0 shares
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
50542 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
187464 usd
AVNI Allocated Share Based Compensation Expense Remaining
AllocatedShareBasedCompensationExpenseRemaining
472713 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
62489 shares
CY2024Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
239421 shares
CY2025Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
156902 shares
CY2026Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
7582 shares
CY2027Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
6319 shares
AVNI Allocated Share Based Compensation Expense Remaining
AllocatedShareBasedCompensationExpenseRemaining
472713 usd
CY2023Q3 us-gaap Notes Payable
NotesPayable
898054 usd
CY2022Q4 us-gaap Notes Payable
NotesPayable
0 usd
CY2023Q3 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
46114 usd
CY2023Q3 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
851940 usd
CY2022Q4 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
0 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
0 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths
46114 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo
710857 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree
11655 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour
12512 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive
8304 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive
108612 usd
CY2023Q3 us-gaap Loans Payable
LoansPayable
22135 usd

Files In Submission

Name View Source Status
avni-20230930_cal.xml Edgar Link unprocessable
0001607062-23-000499-index-headers.html Edgar Link pending
0001607062-23-000499-index.html Edgar Link pending
0001607062-23-000499.txt Edgar Link pending
0001607062-23-000499-xbrl.zip Edgar Link pending
avni-20230930.xsd Edgar Link pending
avni093023form10q.htm Edgar Link pending
ex31.htm Edgar Link pending
ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
avni-20230930_lab.xml Edgar Link unprocessable
avni-20230930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
avni093023form10q_htm.xml Edgar Link completed
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
avni-20230930_def.xml Edgar Link unprocessable